The study on methotrexate therapy in collagen induced arthritis rats
Xiuqing Yan, Fangfang Wang, Fengmei Ge, Kangsheng Li
Abstract
Xiuqing Yan, Fangfang Wang, Fengmei Ge, Kangsheng Li
Abstract
Objective To explore the circadian rhythm of interleukin(IL)-6 in collagen induced arthritis(CIA)rats and investigate the effectiveness and safety of methotrexate(MTX)administered according to IL-6 rhythm. Methods Serum IL-6 concentrations of CIA and normal rats at different time points were measured by enzyme-linked immunosorbent assay(ELISA). CIA rats were randomly divided into the experimental group A, experimental group B and control group. MTX(1/7 mg·kg-1 • d-1)was administered once a day when the IL-6 level began to increase or decrease in the experimental group, while MTX(1 mg/kg)administered once a week in the control group. Arthritis scores and leukocyte counts were observed. The production of IL-6 and C reactive protein(CRP)levels in the serum were measured. Moreover, histological changes in the ankle joint were examined. One-way analysis of variance(ANOVA), two independent sample t test were used to evaluate the experimental data. Results The plasma IL-6 levels in CIA rats were different at different time points, which began to increase at 18:00 and decrease at 6:00. Arthritis score in the experimental group A(4.8±0.7)was lower than that in the control group(5.8±1.0, t=2.256, P=0.0406)and experimental group B(5.5±0.5, t=2.393, P=0.031 3). The levels of TNF-α[(185±21)ng/L], IL-6[(99±6)ng/L], IL-1β[(20.1±1.6)ng/L]and CRP[(1 251 ±282)μg/L]in the experimental group A were significantly lower than those in control group[TNF-α:(207±10)ng/L, t=2.726, P=0.016 4; IL-6:(100±6)ng/L, t=2.669, P=0.018 3; IL-1β:(22.0±1.3)ng/L, t=2.814, P=0.013 8; CRP:(1 417 ±278)μg/L, t=2.369, P=0.032 7]. The level of IL-6 in the experimental group A[(93 ±6)ng/L]was lower than that in the experimental group B[(99 ±6)ng/L, t=2.323, P=0.035 8]. Compared with the control group[(9 650 ±1 062)/μl], the counts of leukocyte in the experimental group A[(4 595 ± 603)/μl, t=3.841, P=0.006 4]and experimental group B[(3 833±585)/μl, t=4.442, P=0.003]were significantly lower. Compared with the control group(9.1 ±2.0), histopathology scores in the experimental group A(6.6 ± 1.3, t= 2.606, P=0.015)and experimental group B(7.4±1.3, t=3.857, P=0.000 7)were significantly lower. Conclusion The plasma IL-6 levels in CIA rats have shown evident circadian rhythm. There-fore, once a day administration is better than once a week. The therapeutic effect of RA may be improved by administering MTX at the time points according to the circadian rhythm of IL-6. Key words: Arthritis, rheumatoid; Chronotherapy; Methotrexate
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the circadian rhythm of interleukin(IL)-6 in collagen induced arthritis(CIA)rats and investigate the effectiveness and safety of methotrexate(MTX)administered according to IL-6 rhythm. Methods Serum IL-6 concentrations of CIA and normal rats at different time points were measured by enzyme-linked immunosorbent assay(ELISA). CIA rats were randomly divided into the experimental group A, experimental group B and control group. MTX(1/7 mg·kg-1 • d-1)was administered once a day when the IL-6 level began to increase or decrease in the experimental group, while MTX(1 mg/kg)administered once a week in the control group. Arthritis scores and leukocyte counts were observed. The production of IL-6 and C reactive protein(CRP)levels in the serum were measured. Moreover, histological changes in the ankle joint were examined. One-way analysis of variance(ANOVA), two independent sample t test were used to evaluate the experimental data. Results The plasma IL-6 levels in CIA rats were different at different time points, which began to increase at 18:00 and decrease at 6:00. Arthritis score in the experimental group A(4.8±0.7)was lower than that in the control group(5.8±1.0, t=2.256, P=0.0406)and experimental group B(5.5±0.5, t=2.393, P=0.031 3). The levels of TNF-α[(185±21)ng/L], IL-6[(99±6)ng/L], IL-1β[(20.1±1.6)ng/L]and CRP[(1 251 ±282)μg/L]in the experimental group A were significantly lower than those in control group[TNF-α:(207±10)ng/L, t=2.726, P=0.016 4; IL-6:(100±6)ng/L, t=2.669, P=0.018 3; IL-1β:(22.0±1.3)ng/L, t=2.814, P=0.013 8; CRP:(1 417 ±278)μg/L, t=2.369, P=0.032 7]. The level of IL-6 in the experimental group A[(93 ±6)ng/L]was lower than that in the experimental group B[(99 ±6)ng/L, t=2.323, P=0.035 8]. Compared with the control group[(9 650 ±1 062)/μl], the counts of leukocyte in the experimental group A[(4 595 ± 603)/μl, t=3.841, P=0.006 4]and experimental group B[(3 833±585)/μl, t=4.442, P=0.003]were significantly lower. Compared with the control group(9.1 ±2.0), histopathology scores in the experimental group A(6.6 ± 1.3, t= 2.606, P=0.015)and experimental group B(7.4±1.3, t=3.857, P=0.000 7)were significantly lower. Conclusion The plasma IL-6 levels in CIA rats have shown evident circadian rhythm. There-fore, once a day administration is better than once a week. The therapeutic effect of RA may be improved by administering MTX at the time points according to the circadian rhythm of IL-6. Key words: Arthritis, rheumatoid; Chronotherapy; Methotrexate
Key concepts: Methotrexate, Rheumatoid arthritis, Medicine, Arthritis, Analysis of variance, Internal medicine, Interleukin, Endocrinology